Arti Patel

Company: Novartis AG

Job title: Principal Scientist & Group Leader

Seminars:

Workshop C: To What Extent Does TDP-43 Underlie ALS Pathology? Evaluating Novel Target Discovery & Validation to Address the Breadth of ALS Pathology 1:00 pm

This workshop will delve into TDP-43’s role as a key driver of ALS pathology and explore broader mechanisms contributing to disease heterogeneity. Attendees will critically assess TDP-43 as a therapeutic target, how well TDP-43 accounts for all ALS pathology in sporadic ALS, identify other pathological drivers such as neuroinflammation and metabolic dysfunction, and refine preclinical…Read more

day: Pre Conference Day PM